The following sections are included:Prostate CancerLeukemiaPancreatic CancerLymphoma#Prostate Cancer#Leukemia#Pancreatic Cancer#LymphomaCANCER MANAGEMENT WITH CHINESE MEDICINE:Prevention and Complementary TreatmentsRENCUN YUBeijing Hospital of Traditional Chinese Medicine, ChinaHAI HONG...
Besides its well-known role in mineral and bone homeostasis, non-classical effects of vitamin D have been increasingly recognized, such as modulation of growth, differentiation, and function of various cell types, regulation of immune responses, cardiovascular processes, and cancer prevention.20,277 ...
We have been able to detect soluble interleukin-2 receptors (IL-2R) in pretreatment sera from 80 patients with undifferentiated lymphoma (predominantly Burkitt's lymphoma) and lymphoblastic lymphoma. The demonstration of IL-2R in lymphom... DK Wagner,J Kiwanuka,BK Edwards,... - 《Journal of ...
A. (2006) Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control. Oncogene 25, 2565-2574Sanchez-Aguilera A, Garcia JF, Sanchez-Beato M, Piris MA. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple ...
Drug resistance is a common cause of treatment failure in cancer patients and encompasses a multitude of different mechanisms. The aim of the present study was to identify drugs effective on multidrug resistant cells. The RPMI 8226 myeloma cell line and
We have identified two lung carcinoma cell lines, A549 and Calu-1, expressing low levels of the macrophage colony-stimulating factor (CSF-1) receptor (CSF-... AE Filderman,A Bruckner,BM Kacinski,... - 《Cancer Research》 被引量: 283发表: 1992年 Direct stimulation of cells expressing rece...
for Patients with Previously Untreated Mantle Cell Lymphoma Calquence approval historyOmvoh (mirikizumab-mrkz) Injection New Indication Approved: January 15, 2025 Date of Original Approval: October 26, 2023 Omvoh (mirikizumab-mrkz) is an interleukin-23 antagonist used for the treatment of ...
B-cell lymphoma-2 CK-MB: Creatine kinase isoenzymes CHOP: CCCAT-enhancer binding protein homologous protein CAN: Calcineurin CDK2: Cyclin-dependent kinases 2 CTX-1: Cross linked C-telopeptide of type I collagen CCL2: C–C motif chemokine ligand 2 ...
1.39 "Hematologic Oncology Indication" means a cancerous disease of the blood or bone marrow, including non-Hodgkin's lymphoma, multiple myeloma, chronic lymphocytic leukemia, acute lymphocytic leukemia, Hodgkin's disease and Waldenstrom's macroglobulinemia. For clarification and purposes of calculating ...
With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primar...